Ledger.Open graph →
SEC Form D · filed April 19, 2016

Axon Therapies Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Mitchell S. Bloom · New York, NYExecMark R. Gelfand · New York, NYExecHoward R. Levin · New York, NYExec · DirectorPaul S. Laviolette · New York, NYDirectorWadstrom Nicolai · San Francisco, CAExec · DirectorCarl J. Tippit · Cleveland, OHExecBradley M. Anderson · New York, NYDirectorBenjamin Levy · San Francisco, CAExecDavid Dunn · Wilton, CTDirectorNicolai Wadstrom · San Francisco, CAExec · DirectorRagan Young · Dallas, TXExecRobert A. Granieri · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗